# Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLC

> **NCT02275806** · PHASE2 · TERMINATED · sponsor: **Leo W. Jenkins Cancer Center** · enrollment: 4 (actual)

## Conditions studied

- Lung Neoplasms, Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Irinotecan
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT02275806
- **Lead sponsor:** Leo W. Jenkins Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2017-09-27
- **Final completion:** 2017-09-27
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** PI decided to terminate study
- **Last updated:** 2019-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02275806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02275806, "Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLC". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02275806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*